About the Equity Working Group
In the field of outcome research, instruments (tools used to measure outcomes) are a potential source of health inequity. This is because they are often developed and tested in populations who regularly take part in research i.e. predominantly white, middle class and well-educated. As a result, they may not measure the outcome as well when applied to under-represented populations.
The aim of this working group is to describe the key questions for researchers to consider to promote health equity when developing or using outcome measures in rheumatology. We will discuss the key ways that population differences can be considered when developing or selecting an instrument for a study.

Jennifer Barton
Co-Chair

Peter Brooks
Co-Chair

Francis Guillemin
Co-Chair

Jennifer Petkovic
Co-Chair

Peter Tugwell
Co-Chair
Aimee Wattiaux
Fellow

Willemina Campbell
Patient Research Partner

Regina Greer-Smith
Patient Research Partner

Catherine Hofstetter
Patient Research Partner
Equity Working Group Overview
OMERACT 2020 Virtual Equity Special Interest Group
Working Group Publications
Working Group Members:
Cheryl Barnabe
Christie Bartels
Jennifer Barton
Dorcas Beaton
Annelies Boonen
Peter Brooks
Rachelle Buchbinder
Willemina Campbell
Robin Christensen
Maarten de Wit
Jonathan Epstein
Niti Goel
Allyson Jones
Charles Goldsmith
Regina Greer Smith
Glen Hazelwood
Catherine Hofstetter
Jenny Humphreys
Janet Jull
Diane Lacaille
Alex Lee
Anne Lyddiatt
Lara Maxwell
Sabrina Mai Neilsen
Jordi Pardo Pardo
Adewale O Adebajo
Jennifer Petkovic
Christoph Pohl
Tamara Rader
Nancy Santesso
Bev Shea
Jasvinder Singh
Antoine Sreih
Karine Toupin-April
Peter Tugwell
Valerie Umaefulam
Aimée Wattiaux
Vivian Welch
Grayson Schultz